(NYSE: EVMN) (the “Company” or “Evommune”), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, today announced top-line ...

The City Council chose an incremental approach to the charges, which are meant to offset the impact of housing production on ...

The FDA plans to hold an advisory committee meeting to discuss Capricor Therapeutics’ application for deramiocel, which the agency rejected last July. The news surprised CEO Linda Marbán, who told ...

A study published in Nature Physics provides new molecular-level evidence from simulations that liquid water is not a single uniform substance, but a constantly shifting mixture of two distinct ...

When Santa Cruz Metro was forced to confront bleak financial forecasts in 2008, 2012 and 2016, the solution was the same.

Former Vice President Mike Pence cast doubt on the possibility of a deal between Iran and the U.S. over the two countries’ war shortly before President Trump announced a deal has been reached on ...

ISLAMABAD (AP) — The United States and Iran once again appear close to a deal to end the war and open the Strait of Hormuz. Pakistani Prime Minister Shehbaz Sharif said Saturday that a deal aimed at ...

Copyright: © 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Constellation’s $1.6B plan to bring nuclear back to Three Mile Island—now called the Crane Clean Energy Center—has cleared a major hurdle. FERC is allowing Constellation to transfer 760 MW of Capacity ...

This documentary examines the long-term outlook for human civilization, arguing that despite daunting existential risks, we possess the resilience and technological capacity to overcome these ...

Switching to an investigational once-weekly oral tablet of islatravir/lenacapavir successfully maintained viral suppression at 48 weeks, with a safety profile comparable to daily regimens. Topline ...

The update is a blow for an asset that Sanofi lists among its key mid- and late-stage programs. (Jwala Kotesh/NurPhoto/Getty Images) Sanofi has stopped a phase 3 autoimmune clinical trial early after ...